ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,161,000 | -20.3% | 153,298 | -9.7% | 0.02% | -9.5% |
| Q2 2023 | $5,219,000 | -23.5% | 169,782 | -10.3% | 0.02% | -25.0% |
| Q1 2023 | $6,821,000 | -11.2% | 189,320 | -2.5% | 0.03% | -15.2% |
| Q4 2022 | $7,677,000 | +0.8% | 194,268 | +2.5% | 0.03% | -2.9% |
| Q3 2022 | $7,618,000 | -2.4% | 189,596 | +2.1% | 0.03% | +3.0% |
| Q2 2022 | $7,808,000 | -15.1% | 185,727 | -21.3% | 0.03% | +3.1% |
| Q1 2022 | $9,200,000 | +31.2% | 236,141 | +34.2% | 0.03% | +33.3% |
| Q4 2021 | $7,011,000 | +6.4% | 175,939 | -3.5% | 0.02% | +4.3% |
| Q3 2021 | $6,588,000 | -13.6% | 182,299 | -2.0% | 0.02% | -14.8% |
| Q2 2021 | $7,627,000 | +1.7% | 186,071 | +8.3% | 0.03% | -10.0% |
| Q1 2021 | $7,496,000 | +180.1% | 171,839 | +221.4% | 0.03% | +150.0% |
| Q4 2020 | $2,676,000 | – | 53,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |